Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC.NTHI · Entity 6646 | Chief Clinical Officer | April 23, 2026 | April 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEONC TECHNOLOGIES HOLDINGS, INC.
Report date April 23, 2026 · Filed April 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,760 |
Reported balance
After 2026-04-23 transaction · row 1
1 source rowRow 1 · 2026-04-23 · Purchase · Acquired 500 · Balance 134,760 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 23, 2026 Filed Apr 24, 2026 22:10 UTC | NEONC TECHNOLOGIES HOLDINGS, INC. NTHI · Entity 6646 | PurchaseCommon Stock | 500 | $4.88 | $2,440.00 |
DisclosureSEC source: 0001213900-26-047648 · marketforms-72995.xml · nonDerivative · entry 1 Neman-Ebrahim Yousha · CIK 0002071642 · Chief Clinical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,760 Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 22:46 UTC | NEONC TECHNOLOGIES HOLDINGS, INC. NTHI · Entity 6646 | PurchaseCommon Stock | 1,100 | $6.69 | $7,359.00 |
DisclosureSEC source: 0001213900-25-114257 · marketforms-71333.xml · nonDerivative · entry 1 Neman-Ebrahim Yousha · CIK 0002071642 · Chief Clinical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,260 Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 23:40 UTC | NEONC TECHNOLOGIES HOLDINGS, INC. NTHI · Entity 6646 | GrantCommon Stock · Derivative | 67,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-25-052777 · marketforms-69803.xml · derivative · entry 2 Neman-Ebrahim Yousha · CIK 0002071642 · Chief Clinical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 67,000 shares Expires not disclosed F4 · security: Restricted common stock granted pursuant to Issuer's Incentive Plan. Vesting and exercise of such shares are based on achievement of certain performance metrics. See also footnote 1. F3 · derivative.exercise_price: Not applicable. F3 · price: Not applicable. F4 · derivative.exercise_date: Restricted common stock granted pursuant to Issuer's Incentive Plan. Vesting and exercise of such shares are based on achievement of certain performance metrics. See also footnote 1. F3 · derivative.expiration_date: Not applicable. F5 · derivative.underlying_shares: This is a target number only. The actual number of shares of common stock deliverable is subject to adjustment as described in the Agreement. Reporting Person may acquire shares of Issuer's common stock to the extent that the performance metrics have been achieved. See also footnote 1. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 23:40 UTC | NEONC TECHNOLOGIES HOLDINGS, INC. NTHI · Entity 6646 | GrantCommon Stock | 133,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-25-052777 · marketforms-69803.xml · nonDerivative · entry 1 Neman-Ebrahim Yousha · CIK 0002071642 · Chief Clinical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,000 F1 · security: Shares of restricted common stock ("Restricted Stock") granted pursuant to Issuer's 2023 Equity Incentive Plan (the "Incentive Plan"). Pursuant to Reporting Person's Restricted Stock Award Agreement dated June 5, 2025 (the "Agreement"), Issuer granted a total of 200,000 shares of common stock to Reporting Person. Of such shares, (i) 66,000 shares vest seventh months from the date of grant, (ii) one-third, or approximately 67K shares, vest in 29 equal monthly installments thereafter, and (iii) the remaining one-third, or approximately 67K shares, are performance based with vesting predicated on achievement of certain performance metrics. F2 · shares: See footnote 1. F3 · price: Not applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.